Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
Contents:; The International System for Reporting Serous Fluid Cytopathology: Introduction and Overview of Diagnostic Terminology and Reporting -- Non-diagnostic (ND) and Adequacy -- Negative for Malignancy (NFM) -- Atypia of Undetermined Significance -- Suspicious for Malignancy (SFM) -- Malignant…
"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer…